Results 91 to 100 of about 34,984 (234)

Leiomyosarcoma of the Larynx: Case Report and Review of the Literature [PDF]

, 2008
Jayant Sastri Goda, Karuppiah Saravanan, Rajat Vashistha, Vinay Kumar, Ashok Gupta   +4 more
openalex   +1 more source

Uterine leiomyosarcomas harboring MAP2K4 gene amplification are sensitive in vivo to PLX8725, a novel MAP2K4 inhibitor [PDF]

, 2023
Blair McNamara, Justin Harold, Diego Manavella, Stefania Bellone, Levent Mutlu, Tobias M.P. Hartwich, Margherita Zipponi, Yang Yang‐Hartwich, Cem Demirkiran, Miguel Skyler Z. Verzosa, Kevin Yang, Jungmin Choi, Weilai Dong, Natália Buza, Pei Hui, Gary Altwerger, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Elena Ratner, Masoud Azodi, Peter E. Schwartz, Elizabeth A. Burton, Hiroaki Inagaki, Aaron Albers, Chao Zhang, Gideon Bollag, Joseph Schlessinger, Alessandro D. Santin   +28 more
openalex   +1 more source

Single‐nucleus RNA sequencing reveals the distinct heterogeneity of primary pulmonary sarcomas (PPS) and pulmonary sarcomatoid carcinoma (PSC)

Clinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Single‐nucleus RNA sequencing (snRNA‐seq) maps the cellular diversity of pulmonary sarcomatoid carcinoma (PSC) and primary pulmonary sarcomas (PPS). AT2 cells, a major source of epithelial cells in PSC, underwent malignant transformation primarily through epithelial–mesenchymal transition, suggesting AT2 cells may serve as the origin of PSC.
Jianfei Zhu, Yanlu Xiong, Shouzheng Ma, Jun Wei, Jiakuan Chen, Wenchen Wang, Qianqian Duan, Qin Zhang, Dongsheng Chen, Wanglong Deng, Tao Jiang, Jie Lei   +11 more
wiley   +1 more source

Bifenthrin Under Scrutiny: Revisiting Toxicological Evidence Amid Regulatory Gaps

Journal of Applied Toxicology, Volume 46, Issue 1, Page 61-77, January 2026.
ABSTRACT Despite growing health concerns, bifenthrin (BF) remains widely used for controlling agricultural and residential pests. However, different perspectives on its toxicological profile and regulatory framework warrant a revisit and update on BF regulation towards a robust risk‐safety assessment.
Caroline V. L. Moreira, John Ogbu I, Kadja L. C. Monteiro, Thiago M. de Aquino, Edeildo F. da Silva‐Júnior, Alberto S. S. Filho, Hamilton B. Napolitano, Christianah A. Elusiyan, Renê O. do Couto, Elson A. Costa, James O. Fajemiroye   +10 more
wiley   +1 more source

Summary from the 2025 International Society for Magnetic Resonance in Medicine workshop on body MRI: Unsolved problems and unmet needs

Magnetic Resonance in Medicine, Volume 95, Issue 1, Page 74-85, January 2026.
Abstract In March of 2025, 145 attendees convened at the Hub for Clinical Collaboration of the Children's Hospital of Philadelphia for the inaugural International Society for Magnetic Resonance in Medicine (ISMRM) Body MRI Study Group workshop entitled “Body MRI: Unsolved Problems and Unmet Needs.” Approximately 24% of the attendees were MD or MD/PhD's,
Elizabeth M. Hecht, Houchun Harry Hu, Suraj D. Serai, Holden H. Wu, Ryan L. Brunsing, Alexander R. Guimaraes, Sila Kurugol, Kristina I. Ringe, Ali B. Syed, on behalf of the ISMRM Body MRI Study Group   +9 more
wiley   +1 more source

Ifosfamide‐induced acute kidney injury in a patient with leiomyosarcoma: A case report [PDF]

, 2022
Javad Boskabadi, Ehsan Yousefi‐Mazhin, Ebrahim Salehifar   +2 more
openalex   +1 more source

Comparative Analysis of a Dual DNA–RNA Panel and a DNA‐Only Panel for Sarcoma: Real‐World Data From a Nationwide Genomic Database

Cancer Science, Volume 117, Issue 1, Page 156-168, January 2026.
Dual DNA–RNA panel with matched tumor–normal testing may improve diagnostic accuracy and inform treatment decisions in the routine clinical management of sarcoma. ABSTRACT Next‐generation sequencing‐based comprehensive cancer genomic profiling is promising in cancer management; however, most studies rely on tumor‐only DNA panels from single ...
Eiji Nakata, Kiichiro Ninomiya, Tatsunori Osone, Daisuke Ennishi, Shuta Tomida, Tomohiro Fujiwara, Toshiyuki Kunisada, Mashu Futagawa, Akira Hirasawa, Shinichi Toyooka, Toshifumi Ozaki   +10 more
wiley   +1 more source

Leiomyosarcoma of the Penis: A Case Report and Re-Appraisal [PDF]

, 2022
Zainub Ajmal
openalex   +1 more source

Secondary Lower‐Body Sarcomas in Cervical Cancer Survivors Following Surgery, Radiotherapy, or Both: A Population‐Based Study

Cancer Science, Volume 117, Issue 1, Page 216-225, January 2026.
Secondary lower‐body sarcoma incidence was higher in cervical cancer survivors treated with radiotherapy or surgery plus radiotherapy than in those treated with surgery. Angiosarcoma incidence was higher with surgery plus radiotherapy than with radiotherapy.
Toshiki Ikawa, Kayo Nakata, Toshitaka Morishima, Ken‐ichi Yoshida, Yoshihiro Kuwabara, Mizuki Shimadzu Kato, Yoko Iwaki, Naoyuki Kanayama, Masahiro Morimoto, Koji Konishi, Isao Miyashiro   +10 more
wiley   +1 more source

High Immunohistochemical Expression of SETD5 as a Candidate Pathological Factor for Dedifferentiation and Prognosis in Liposarcoma

Pathology International, Volume 76, Issue 1, January 2026.
SET domain containing 5 (SETD5), a chromatin regulator involved in adipocytic differentiation. However, its immunohistochemical expression and prognostic significance in liposarcoma remain unclear. In our study, SETD5 expression was markedly elevated in the dedifferentiated component of dedifferentiated liposarcoma compared to the well‐differentiated ...
Makoto Abe, Naoto Kubota, Ken Yamazaki, Eisuke Miura, Kaoru Hirabayashi, Masatsugu Ishii, Hirofumi Shirakawa, Kazutaka Kikuta, Yudai Murayama, Rumi Nakagawa, Hidenori Ojima   +10 more
wiley   +1 more source